Martin Samuel Bates 4
4 · Celldex Therapeutics, Inc. · Filed Jun 9, 2025
Insider Transaction Report
Form 4
Martin Samuel Bates
SVP AND CFO
Transactions
- Award
Incentive Stock Option (right to buy)
2025-06-05+81,000→ 81,000 totalExercise: $19.53From: 2026-06-05Exp: 2035-06-05→ Common Stock (81,000 underlying)
Footnotes (2)
- [F1]Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan.
- [F2]25% vest on June 5, 2026 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.